Mednax INC (MD) Stake Maintained by Earnest Partners Llc

April 16, 2018 - By Adrian Mccoy

MEDNAX, Inc. (NYSE:MD) Logo

Earnest Partners Llc increased its stake in Mednax Inc (MD) by 48.07% based on its latest 2017Q4 regulatory filing with the SEC. Earnest Partners Llc bought 718,317 shares as the company’s stock rose 2.30% while stock markets declined. The institutional investor held 2.21M shares of the health care company at the end of 2017Q4, valued at $118.25 million, up from 1.49 million at the end of the previous reported quarter. Earnest Partners Llc who had been investing in Mednax Inc for a number of months, seems to be bullish on the $4.91 billion market cap company. The stock increased 0.02% or $0.01 during the last trading session, reaching $52.6. About 397,494 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 21.42% since April 16, 2017 and is downtrending. It has underperformed by 32.97% the S&P500.

Earnest Partners Llc, which manages about $24.92 billion and $10.44 billion US Long portfolio, decreased its stake in Franklin Elec Co (NASDAQ:FELE) by 163,547 shares to 2.13M shares, valued at $97.69M in 2017Q4, according to the filing. It also reduced its holding in Stifel Financial (NYSE:SF) by 75,421 shares in the quarter, leaving it with 1.62 million shares, and cut its stake in Raymond James (NYSE:RJF).

MEDNAX, Inc. (NYSE:MD) Ratings Coverage

Among 12 analysts covering Mednax (NYSE:MD), 4 have Buy rating, 0 Sell and 8 Hold. Therefore 33% are positive. Mednax had 17 analyst reports since October 17, 2017 according to SRatingsIntel. The company was maintained on Monday, February 12 by JP Morgan. The firm has “Hold” rating given on Friday, February 9 by Mizuho. The stock of MEDNAX, Inc. (NYSE:MD) has “Neutral” rating given on Friday, November 3 by Citigroup. The rating was maintained by KeyBanc Capital Markets on Monday, December 4 with “Buy”. The firm earned “Hold” rating on Thursday, February 8 by Robert W. Baird. As per Thursday, February 8, the company rating was maintained by SunTrust. The firm has “Market Perform” rating given on Monday, February 12 by BMO Capital Markets. The firm earned “Hold” rating on Wednesday, January 24 by Mizuho. As per Wednesday, November 1, the company rating was maintained by KeyBanc Capital Markets. The firm earned “Hold” rating on Wednesday, December 20 by SunTrust.

MEDNAX, Inc. (NYSE:MD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.